Research goal Novel vaccine adjuvants and delivery system Development of a vaccine adjuvant and POC with candidate vaccine antigens Improved efficacy profile for high-risk groups (elderly or immunocompromised group) Dose-sparing effects for healthy population Development of novel delivery platforms and POC with candidate vaccine antigens Vectored or nucleic acid-based delivery as rapid response to outbreak Needle-free delivery of antigens for enhanced efficacy and safety profile